Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Compare the effect of milrinone versus sildenafil in treatment of neonates with persistent pulmonary hypertension.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rania Ali El-Farrash
• Treatments: Milrinone; Sildenafil Citrate

Criteria

Inclusion Criteria:

• gestational age >34 weeks

• postnatal age <10 days

Exclusion Criteria:

• neonates with congenital heart disease

• neonates with congenital diaphragmatic hernia